tailieunhanh - Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study

Only a few patients with pancreatic ductal adenocarcinoma (PDAC) recurring after curative resection and peri-operative (neoadjuvant and adjuvant) therapy are included in clinical trials of metastatic PDAC. | Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy A retrospective study

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN